Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001192482-19-000024
Filing Date
2019-01-14
Accepted
2019-01-14 14:05:27
Documents
1
Effectiveness Date
2019-01-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9220
  Complete submission text file 0001192482-19-000024.txt   10288
Mailing Address 610 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462
Business Address 610 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462 215-767-4184
Mirata Pharmaceuticals, LLC (Filer) CIK: 0001742436 (see all company filings)

EIN.: 824746856 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-313995 | Film No.: 19524758